An increasing number of studies have investigated the clinicopathology and molecular character of prostate cancer with neuroendocrine differentiation in the past years, but the understanding of AR status in prostate cancer neuroendocrine differentiation progression remains controversial. Here, AR is linked to prostate carcinoma.